Corporate | 25 April 2016 19:33
Eckert & Ziegler subscribes to capital increase at BEBIG
|
DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Investment/Miscellaneous
Berlin / Seneffe, April 25, 2016. At today’s meeting, the Board of Directors of Eckert & Ziegler BEBIG s.a. in Belgium resolved to propose to the Annual General Meeting on June 9, 2016 a capital increase with the exclusion of subscription rights of minority shareholders. Eckert & Ziegler AG, which already owns just under 75% of the dividend-bearing shares, will be the subscriber. With this subscription, the company will increase its shareholding to around 80%. The planned capital inflow of some EUR 5 million is intended to strengthen the equity base and will be used to repay debt. More details on the capital increase are available in the press release published by Eckert & Ziegler BEBIG s.a. on its website: http://www.bebig.com/international/press/press-releases.html
With around 700 employees, Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) is one of the world’s largest providers of isotope technology components for radiation therapy and nuclear medicine.
2016-04-25 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
|
| Language: | English | |
| Company: | Eckert & Ziegler Strahlen- und Medizintechnik AG | |
| Robert-Rössle-Str.10 | ||
| 13125 Berlin | ||
| Germany | ||
| Phone: | 49 30 941084-138 | |
| Fax: | 49 30 941084-112 | |
| E-mail: | karolin.riehle@ezag.de | |
| Internet: | www.ezag.de | |
| ISIN: | DE0005659700 | |
| WKN: | 565970 | |
| Listed: | Regulated Market in Frankfurt (Prime Standard), Stuttgart; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich | |
| End of News | DGAP News Service |